Dow Down0.18% Nasdaq Up0.39%

Bovie Medical Corporation (BVX)

4.25 Up 0.01(0.24%) Sep 2, 4:00PM EDT
|After Hours : 4.26 Up 0.01 (0.24%) Sep 2, 4:07PM EDT
ProfileGet Profile for:
Bovie Medical Corporation
5115 Ulmerton Road
Clearwater, NY 33760
United States - Map
Phone: 727-384-2323
Fax: 727-347-9144

Index Membership:N/A
Industry:Medical Instruments & Supplies
Full Time Employees:136

Business Summary 

Bovie Medical Corporation, an energy-based medical device company, develops, manufactures, and markets a range of electrosurgical products and technologies, and related medical products worldwide. The company’s electrosurgery products include desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers battery operated cauteries; and battery operated medical lights for use in ophthalmology, as well as for general surgery, hip replacement surgery, and the placement of endotracheal tubes in emergency and surgical procedures. In addition, the company manufactures physicians’ office use penlights; and a nerve locator stimulator used for identifying motor nerves in hand and facial reconstructive surgery. Further, Bovie Medical Corporation is developing Derm 101 and Derm 102 products, which are 10 watt high frequency desiccators for use in family practice, aesthetics, and dermatology settings; and Seal-N-Cut, a disposable endoscopic surgical handle. The company markets its products through medical distributors to hospitals, doctor’s offices, and other healthcare facilities. Bovie Medical Corporation was founded in 1982 and is based in Clearwater, Florida.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Bovie Medical Corporation

Key Executives 
Mr. Andrew Makrides Esq., 72
Exec. Chairman
Mr. Robert L. Gershon , 47
Chief Exec. Officer and Director
Mr. J. Robert Saron , 61
Pres, Chief Sales & Marketing Officer and Director
Mr. Moshe Citronowicz , 61
Sr. VP
Mr. Peter L. Donato , 44
Chief Financial Officer, Exec. VP, Sec. and Treasurer
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders